Literature DB >> 16053703

Peptide domain involved in the interaction between membrane protein and nucleocapsid protein of SARS-associated coronavirus.

Xiaonan Fang1, Linbai Ye, Khalid Amine Timani, Shanshan Li, Yingchun Zen, Meng Zhao, Hong Zheng, Zhenghui Wu.   

Abstract

Severe acute respiratory syndrome (SARS) is an emerging infectious disease associated with a novel coronavirus (CoV) that was identified and molecularly characterized in 2003. Previous studies on various coronaviruses indicate that protein-protein interactions amongst various coronavirus proteins are critical for viral assembly and morphogenesis. It is necessary to elucidate the molecular mechanism of SARS-CoV replication and rationalize the anti-SARS therapeutic intervention. In this study, we employed an in vitro GST pull-down assay to investigate the interaction between the membrane (M) and the nucleocapsid (N) proteins. Our results show that the interaction between the M and N proteins does take place in vitro. Moreover, we provide an evidence that 12 amino acids domain (194-205) in the M protein is responsible for binding to N protein. Our work will help shed light on the molecular mechanism of the virus assembly and provide valuable information pertaining to rationalization of future anti-viral strategies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16053703     DOI: 10.5483/bmbrep.2005.38.4.381

Source DB:  PubMed          Journal:  J Biochem Mol Biol        ISSN: 1225-8687


  18 in total

1.  Ribonucleocapsid formation of severe acute respiratory syndrome coronavirus through molecular action of the N-terminal domain of N protein.

Authors:  Kumar Singh Saikatendu; Jeremiah S Joseph; Vanitha Subramanian; Benjamin W Neuman; Michael J Buchmeier; Raymond C Stevens; Peter Kuhn
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

Review 2.  Coronavirus pathogenesis.

Authors:  Susan R Weiss; Julian L Leibowitz
Journal:  Adv Virus Res       Date:  2011       Impact factor: 9.937

3.  A single tyrosine in the severe acute respiratory syndrome coronavirus membrane protein cytoplasmic tail is important for efficient interaction with spike protein.

Authors:  Corrin E McBride; Carolyn E Machamer
Journal:  J Virol       Date:  2009-12-09       Impact factor: 5.103

4.  Analyses of Coronavirus Assembly Interactions with Interspecies Membrane and Nucleocapsid Protein Chimeras.

Authors:  Lili Kuo; Kelley R Hurst-Hess; Cheri A Koetzner; Paul S Masters
Journal:  J Virol       Date:  2016-04-14       Impact factor: 5.103

5.  Characterization of an Immunodominant Epitope in the Endodomain of the Coronavirus Membrane Protein.

Authors:  Hui Dong; Xin Zhang; Hongyan Shi; Jianfei Chen; Da Shi; Yunnuan Zhu; Li Feng
Journal:  Viruses       Date:  2016-12-10       Impact factor: 5.048

6.  Small interfering RNA effectively inhibits the expression of SARS coronavirus membrane gene at two novel targeting sites.

Authors:  Ying Wang; Ying-Li Cao; Fan Yang; Yun Zhang; Shu-Hui Wang; Li Liu
Journal:  Molecules       Date:  2010-10-18       Impact factor: 4.411

7.  Identifying SARS-CoV membrane protein amino acid residues linked to virus-like particle assembly.

Authors:  Ying-Tzu Tseng; Chia-Hui Chang; Shiu-Mei Wang; Kuo-Jung Huang; Chin-Tien Wang
Journal:  PLoS One       Date:  2013-05-20       Impact factor: 3.240

8.  Analysis of intraviral protein-protein interactions of the SARS coronavirus ORFeome.

Authors:  Albrecht von Brunn; Carola Teepe; Jeremy C Simpson; Rainer Pepperkok; Caroline C Friedel; Ralf Zimmer; Rhonda Roberts; Ralph Baric; Jürgen Haas
Journal:  PLoS One       Date:  2007-05-23       Impact factor: 3.240

9.  Interactions between M protein and other structural proteins of severe, acute respiratory syndrome-associated coronavirus.

Authors:  Yi-Ching Hsieh; Hui-Chun Li; Shih-Chi Chen; Shih-Yen Lo
Journal:  J Biomed Sci       Date:  2008-09-16       Impact factor: 8.410

10.  The membrane protein of SARS-CoV suppresses NF-kappaB activation.

Authors:  Xiaonan Fang; Jinrong Gao; Hong Zheng; Baozong Li; Lingbao Kong; Yijuan Zhang; Wei Wang; Yingchun Zeng; Linbai Ye
Journal:  J Med Virol       Date:  2007-10       Impact factor: 2.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.